Surface Tethering of Inflammation-Modulatory Nanostimulators to Stem Cells for Ischemic Muscle Repair
- 3 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (5) , 5298-5313
Abstract
Stem cell transplantation has been a promising treatment for peripheral arterial diseases in the past decade. Stem cells act as living bioreactors of paracrine factors that orchestrate tissue regeneration. Prestimulated adipose-derived stem cells (ADSCs) have been proposed as potential candidates but have been met with challenges in activating their secretory activities for clinical use. Here, we propose that tethering the ADSC surface with nanoparticles releasing tumor necrosis factor α (TNFα), named nanostimulator, would stimulate cellular secretory activity in situ. We examined this hypothesis by complexing octadecylamine-grafted hyaluronic acid onto a liposomal carrier of TNFα. Hyaluronic acid increased the liposomal stability and association to CD44 on ADSC surface. ADSCs tethered with these TNFα carriers exhibited up-regulated secretion of proangiogenic vascular endothelial growth factor and immunomodulatory prosteoglandin E2 (PGE2) while decreasing secretion of antiangiogenic pigment epithelium-derived factors. Accordingly, ADSCs tethered with nanostimulators promoted vascularization in a 3D microvascular chip and enhanced recovery of perfusion, walking, and muscle mass in a murine ischemic hindlimb compared to untreated ADSCs. We propose that this surface tethering strategy for in situ stimulation of stem cells would replace the costly and cumbersome preconditioning process and expedite clinical use of stem cells for improved treatments of various injuries and diseases.Keywords
Funding Information
- Agency for Science, Technology and Research
- National Heart, Lung, and Blood Institute (1R21 HL131469)
- Korea Institute of Science and Technology (2E29340)
- Institute of Bioengineering and Nanotechnology
This publication has 62 references indexed in Scilit:
- Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical successDisease Models & Mechanisms, 2013
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- Polyfunctional responses by human T cells result from sequential release of cytokinesProceedings of the National Academy of Sciences, 2011
- Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune responseJournal of Controlled Release, 2011
- Analysis of CD44-Hyaluronan Interactions in an Artificial Membrane SystemJournal of Biological Chemistry, 2010
- Tetrabenazine is neuroprotective in Huntington's disease miceMolecular Neurodegeneration, 2010
- Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factorsProceedings of the National Academy of Sciences, 2009
- Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial progenitor cellsJournal of Vascular Surgery, 2009
- Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cellsJournal of Tissue Engineering and Regenerative Medicine, 2009
- Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesisJournal of Vascular Surgery, 2009